Showing 341-350 of 7529 results for "".
Clinical Conversations: How JAK Inhibitors are Changing the AD Treatment Landscape
https://practicaldermatology.com/series/jak-inhibitors-in-practice/clinical-conversations-how-jak-inhibitors-are-changing-the-ad-treatment-landscape/20092/With the approval of JAK inhibitors to treat eczema, the treatment landscape is changing. Matt Zirwas, MD and Adelaide Hebert, MD talk about the role for JAK inhibitors and key considerations for discussing options with patients.Clinical Conversations: MOA of JAK Inhibitors in Dermatology
https://practicaldermatology.com/series/jak-inhibitors-in-practice/clinical-conversations-moa-of-jak-inhibitors-in-dermatology/20096/JAK inhibitors have a range of potential applications in clinical dermatology. In the first video of this series, Brad Glick, DO and Raj Chovatiya, MD explain the mechanism of action of JAK inhibitors and explain how they may be used topically or systemically to treat skin diseases like atopic dermaChallenging Cases
https://practicaldermatology.com/conferences/maui-derm-2022/challenging-cases/20054/Seemal R. Desai, MD was part of the Challenging Cases session on everything from new infectious diseases to challenging surgical and aesthetic complications. He says dermatologists play an important role in saving and transforming patients' lives.Cosmetic Surgery Forum: 2021 Recap
https://practicaldermatology.com/topics/skin-cancer-photoprotection/cosmetic-surgery-forum-2021-recap/20032/Cosmetic Surgery Forum founder and director Joel Schlessinger, MD offers an overview of the 2021 conference in Nashville.DermWireTV: Cosentyx for Kids; Anifrolumab for SLE, Tremfya in PsA at EULAR
https://practicaldermatology.com/topics/psoriasis/dermwiretv-cosentyx-for-kids-anifrolumab-for-sle-tremfya-in-psa-at-eular/19948/FDA has approved Cosentyx (secukinumab) from Novartis for patients as young as six years old. The 2nd Annual San Diego Dermatology Symposium kicks off as a live Virtual Experience next Friday. A post-hoc analysis of pooled data from the TULIP Phase 3 clinical trials shows that anifrolumab improvesScientifically Speaking: When Accidents Happen in the Surgical/Aesthetic Clinic
https://practicaldermatology.com/topics/practice-management/scientifically-speaking-when-accidents-happen-in-the-surgicalaesthetic-clinic/19906/Surgical and laser procedures bring risks for infections, ocular injury, scarring, and more. In the second of a 2-part series, experts discuss best practices for managing adverse reactions with an emphasis on early intervention. Host Joel L. Cohen, MD leads the conversation with Mathew Avram, MD, JDDermWireTV: Candela + Merz Aesthetics Partnership, COVID-19 Vaccines & Fillers, Almirall's Klisyri, MetSyn & PsO
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-candela-merz-aesthetics-partnership-covid-19-vaccines-and-fillers-almiralls-klisyri-metsyn-and-pso/19893/Klisyri® (tirbanibulin) ointment 1% from Almirall will be available for treatment of AKs by the end of this quarter; Ayman Grada, MD discusses. Are patients who have received dermal filler injections at risk for developing reactions to the COVID-19 vaccine? Joel L. Cohen, MD and Doris Day, MD weighGene Biomarker Research and Implications for Care
https://practicaldermatology.com/topics/psoriasis/gene-biomarker-research-and-implications-for-care/23374/A tape strip test can differentiate psoriasis from atopic dermatitis based on genetic analysis. How may the finding affect care?DermWireTV: Dermatology Moves Beyond the COVID-19 Crisis
https://practicaldermatology.com/topics/practice-management/dermwiretv-dermatology-moves-beyond-the-covid-19-crisis/19815/This special edition of DermWireTV takes a look at the dermatology space as offices reopen. Includes updates on disease spread from WHO, advice on PCR and antibody testing, as well as tips for reopening from Suneel Chilukuri, MD (Refresh Dermatology) and Kimberly Campbell. Plus, Amy Forman Taub, MDCaring for Acne and Rosacea Patients in the COVID-19 Era
https://practicaldermatology.com/topics/acne-rosacea/caring-for-acne-and-rosacea-patients-in-the-covid-19-era/23280/Telederm may not be ideal, but it is essential for acne and rosacea patients today—and could persist in the future.